Low-dose oral minoxidil improves hair length and global hair density in short anagen syndrome - 30/04/24
Doi : 10.1016/j.jaad.2024.03.040
Anthony Moussa, MBBS, MS, MSc, MMed a, ⁎ 
, Emadodin Darchini-Maragheh, MD a, b, Dmitri Wall, MB BCh, BAO, MSc Health Informatics c, d, Nekma Meah, MBChB, MRCP(Derm) e, f, Rodney Sinclair, MBBS, MD a, b
, Emadodin Darchini-Maragheh, MD a, b, Dmitri Wall, MB BCh, BAO, MSc Health Informatics c, d, Nekma Meah, MBChB, MRCP(Derm) e, f, Rodney Sinclair, MBBS, MD a, b a Sinclair Dermatology, East Melbourne, VIC, Australia
b Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia
c Hair Restoration Blackrock, Dublin, Ireland
d National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin, Ireland
e Mersey & West Lancashire Teaching Hospitals NHS Trust, Prescot, United Kingdom
f Faculty of Biology, Medicine and Health, Manchester University, Manchester, United Kingdom
∗Correspondence to: Anthony Moussa, MBBS, MS, MSc, MMed, Sinclair Dermatology, 2 Wellington Parade, East Melbourne, Victoria 3002, AustraliaSinclair Dermatology2 Wellington ParadeEast MelbourneVictoria3002Australia
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Tuesday 30 April 2024
Key words : hair, hair disorders, low-dose oral minoxidil, minoxidil, oral minoxidil, pediatric hair disorders, short anagen syndrome, therapy, topical minoxidil
| Funding sources: None. |
|
| Patient consent: Informed patient consent was obtained for the publication of any identifiable patient photographs and medical information at the time of article submission. |
|
| IRB approval status: Not applicable. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?